Company Accounts and Tax Online 01819130 Board of Directors 1.4.24 31.3.25 31.3.25 No description of principal activity false iso4217:GBP xbrli:pure 01819130 2023-04-01 2024-03-31 01819130 2025-03-31 01819130 2024-04-01 2025-03-31 01819130 2024-03-31 01819130 countries:EnglandWales 2024-04-01 2025-03-31 01819130 curr:PoundSterling 2024-04-01 2025-03-31 01819130 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 01819130 uk-bus:Micro-entities 2024-04-01 2025-03-31 01819130 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 01819130 uk-bus:FullAccounts 2024-04-01 2025-03-31 01819130 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 01819130 uk-bus:Director1 2024-04-01 2025-03-31 01819130 uk-bus:Director1 2024-04-01 01819130 uk-bus:Director1 2025-03-31 01819130 core:AfterOneYear 2025-03-31 01819130 core:AfterOneYear 2024-03-31 01819130 core:WithinOneYear 2025-03-31 01819130 core:WithinOneYear 2024-03-31 01819130 core:WithinOneYear 2024-04-01 2025-03-31 01819130 core:AfterOneYear 2025-03-31 01819130 core:AfterOneYear 2024-03-31 01819130 core:AfterOneYear 2024-04-01 2025-03-31 01819130 core:ShareCapital 2025-03-31 01819130 core:ShareCapital 2024-03-31 01819130 core:RevaluationReserve 2025-03-31 01819130 core:RevaluationReserve 2024-03-31 01819130 core:RetainedEarningsAccumulatedLosses 2025-03-31 01819130 core:RetainedEarningsAccumulatedLosses 2024-03-31 01819130 1 2024-04-01 2025-03-31

# TENORCANE LIMITED

## Company Registration Number:
01819130 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 March 2025

## Period of accounts

## Start date: 01 April 2024

## End date: 31 March 2025

# TENORCANE LIMITED

## Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3 |
Profit and Loss Account - 4 |
Balance sheet - 5 |
Footnotes to the Balance Sheet - 7 |

# TENORCANE LIMITED

## Company Information

for the Period Ended 31 March 2025

Registered office: |  | 5 Berkeley Crescent Bristol Avon BS8 1HA
Company Registration Number: |  | 01819130 (England and Wales)

# TENORCANE LIMITED

## Profit and Loss Account

for the Period Ended 31 March 2025

| 2025 £ | 2024 £
--- | --- | ---
Turnover | 0 | 0
Other charges | ( 13 ) | -
Profit or (Loss) for Period | ( 13 ) | 0

# TENORCANE LIMITED

## Balance sheet

As at 31 March 2025

| 2025 £ | 2024 £
--- | --- | ---
Current assets: | 0 | 531
Net current assets (liabilities): | 0 | 531
Total assets less current liabilities: | 0 | 531
Total net assets (liabilities): | 0 | 531
Capital and reserves: | 0 | 531

# TENORCANE LIMITED

## Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 13 September 2025
And Signed On Behalf Of The Board By:

Name: Stuart Greaves
Status: Director

The notes form part of these financial statements

# TENORCANE LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 March 2025

- ## 1. Employee Information

  Average number of employees: 0

# TENORCANE LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 March 2025

- ## 2. Off balance sheet disclosure

  No